Fentanyl Recall: Wells Pharma NDC 73702-202-15
Announced 2026-05-06 · FDA
The recall covers fentanyl citrate injectable solution in 0.9% sodium chloride, 50 mcg per 5 mL. It involves 50 syringes distributed nationwide in the United States. Lot 020226202150202 expires 05/05/2026 and the recall is due to cGMP deviations.
| Brand | Wells Pharma of Houston LLC |
|---|---|
| Product | fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15. |
| Reason | cGMP deviations. |
| Severity | moderate |
| Units affected | 4975 |
| Distribution | U.S. Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use or administer the recalled product.
- Contact Wells Pharma or your healthcare provider for instructions on return or disposal.
- Follow the guidance provided by your healthcare provider or retailer for obtaining a replacement or refund.
How to identify the recalled item
| Lot / date codes | Lot 020226202150202, Exp Date 05/05/2026. |
|---|---|
| Lot / date codes | 120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.